Expanding concept of clinical conditions and symptoms in multiple system atrophy.

作者: Hirohisa Watanabe , Yuichi Riku , Tomohiko Nakamura , Kazuhiro Hara , Mizuki Ito

DOI: 10.5692/CLINICALNEUROL.CN-000903

关键词:

摘要: Multiple system atrophy (MSA) is an adult-onset, progressive neurodegenerative disorder. MSA patients show various phenotypes during the course of their illness including parkinsonism, cerebellar ataxia, autonomic failure, and pyramidal signs. classified into parkinsonian (MSA-P) or (MSA-C) variant depending on clinical motor phenotype at presentation. MSA-P MSA-C are predominant in Western countries Japan, respectively. The mean age onset 55 to 60 years. Prognosis ranges from 6 10 years, but some cases survive for more than 15 Early severe failure a poor prognostic factor. sometimes present with isolated symptoms/signs, median duration concomitant appearance symptoms was approximately 2 years our previous study. As presence combination essential current diagnostic criteria, early diagnosis difficult when symptoms/signs. We experienced who died before presentation symptoms/signs (i.e., premotor MSA). Detection nature consistent identification dysfunctional anatomical sites may increase probability MSA. Dementia another problem Although dementia had been thought be rare MSA, frontal lobe dysfunction observed frequently illness. Magnetic resonance imaging can cerebral longstanding cases. More recently, presenting frontotemporal preceding manifestations have reported. Novel criteria based expanding concept conditions will needed development disease-modifying therapies better management.

参考文章(69)
S Matsubara, S Hirai, E Isozaki, T Hayashida, M Oda, Morphometric study of nucleus ambiguus in multiple system atrophy presenting with vocal cord abductor paralysis. Clinical Neuropathology. ,vol. 19, pp. 213- 220 ,(2000)
Maria G. Cersosimo, Eduardo E. Benarroch, Central control of autonomic function and involvement in neurodegenerative disorders Autonomic Nervous System. ,vol. 117, pp. 45- 57 ,(2013) , 10.1016/B978-0-444-53491-0.00005-5
Brice Laurens, Radu Constantinescu, Roy Freeman, Alexander Gerhard, Kurt Jellinger, Andreas Jeromin, Florian Krismer, Brit Mollenhauer, Michael G. Schlossmacher, Leslie M. Shaw, Marcel M. Verbeek, Gregor K. Wenning, Kristian Winge, Jing Zhang, Wassilios G. Meissner, Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative Neurobiology of Disease. ,vol. 80, pp. 29- 41 ,(2015) , 10.1016/J.NBD.2015.05.004
Shunsuke Koga, Naoya Aoki, Ryan J Uitti, Jay A Van Gerpen, William P Cheshire, Keith A Josephs, Zbigniew K Wszolek, J William Langston, Dennis W Dickson, None, When DLB, PD, and PSP masquerade as MSA An autopsy study of 134 patients Neurology. ,vol. 85, pp. 404- 412 ,(2015) , 10.1212/WNL.0000000000001807
Junichiro Suzuki, Tomohiko Nakamura, Masaaki Hirayama, Yasuaki Mizutani, Akinori Okada, Mizuki Ito, Hirohisa Watanabe, Gen Sobue, Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy. Parkinsonism & Related Disorders. ,vol. 21, pp. 917- 922 ,(2015) , 10.1016/J.PARKRELDIS.2015.05.023
Daniela Berg, Ronald B. Postuma, Charles H. Adler, Bastiaan R. Bloem, Piu Chan, Bruno Dubois, Thomas Gasser, Christopher G. Goetz, Glenda Halliday, Lawrence Joseph, Anthony E. Lang, Inga Liepelt-Scarfone, Irene Litvan, Kenneth Marek, José Obeso, Wolfgang Oertel, C. Warren Olanow, Werner Poewe, Matthew Stern, Günther Deuschl, MDS research criteria for prodromal Parkinson's disease Movement Disorders. ,vol. 30, pp. 1600- 1611 ,(2015) , 10.1002/MDS.26431
David J. Brooks, Klaus Seppi, , Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Movement Disorders. ,vol. 24, pp. 949- 964 ,(2009) , 10.1002/MDS.22413
Matthew D. Cykowski, Elizabeth A. Coon, Suzanne Z. Powell, Sarah M. Jenkins, Eduardo E. Benarroch, Phillip A. Low, Ann M. Schmeichel, Joseph E. Parisi, Expanding the spectrum of neuronal pathology in multiple system atrophy Brain. ,vol. 138, pp. 2293- 2309 ,(2015) , 10.1093/BRAIN/AWV114